Lyell Immunopharma Stock (NASDAQ: LYEL) stock price, news, charts, stock research, profile.
Open | $1.54 |
Close | - |
Volume / Avg. | 693.70K / 919.77K |
Day Range | $1.47 - $1.59 |
52 Wk Range | 1.09 - 3.26 |
Market Cap | $401.92M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 7.63% |
Days to Cover | 23.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Other companies in Lyell Immunopharma’s space includes: KalVista Pharma (NASDAQ:KALV), Inozyme Pharma (NASDAQ:INZY), Korro Bio (NASDAQ:KRRO), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).
Lyell Immunopharma has a consensus price target of $4.00.
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $1.57 last updated September 20, 2024 at 9:26 AM EDT.
There are no upcoming dividends for Lyell Immunopharma.
Lyell Immunopharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Lyell Immunopharma.
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.